A new Beginning..., page-2903

Why start more trials now, when you are awaiting approvals to come in that will allow you to announce commercialisation deals or MOU.? The only thing that more trials at this very point in time are going to do, would be to greatly increase our cash burn rate.
Lets just let them tick off these next few boxes (CE, FDA, Medical Journal publications, etc) and let the RAP team take this to the next stage of its journey, Commercialisation & Revenue!
One a side note, after they have revenue coming in from real world examinations, they may also have large amounts data coming in.? It would obviously depend on if there was further follow up tests undertaken to determine if the original RAP diagnosis was correct & therefore able to be used to further improve the algorithm... (That last part was just a bit of pondering & I am unsure if they are even looking to gather any data from it's real world use)
All of the above IMHO only...

Until I hear further I will wait, and I am sleeping perfectly well at night with my decision.... Goodluck all